RHÖN-KLINIKUM AG 

18.06.2012 17:15

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.



Notification according to section 26 para. 1 WpHG 

Morgan Stanley & Co International Plc, London, UK, Morgan Stanley UK Group,
London, UK, Morgan Stanley Group (Europe), London, UK, Morgan Stanley
International Limited, London, UK, Morgan Stanley International Holdings
Inc, Delaware, USA, and Morgan Stanley, Delaware, USA notified us pursuant
to section 25 WpHG of the following:

1) On 11 June 2012, Morgan Stanley & Co International Plc exceeded the
threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite
1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley &
Co International Plc held 5.18% of the voting rights in RHÖN-KLINIKUM AG
(equals 7,161,101 voting rights). From these voting rights a proportion of
3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant
to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting
rights) is based on (financial / other) instruments pursuant to section 25
WpHG. From the voting rights based on instruments pursuant to section 25
WpHG a proportion of 0.06% (equals 85,500 voting rights) is held indirectly
(chain of controlled undertakings: Morgan Stanley Turnberry Limited, Morgan
Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments
pursuant to section 25 WpHG are retransfer claims based on various
contracts that can be exercised at the lender's discretion.

2) On 11 June 2012, Morgan Stanley UK Group exceeded the threshold of 5% of
the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad
Neustadt a. d. Saale, Germany. On that date, Morgan Stanley UK Group held
5.18% of the voting rights in RHÖN-KLINIKUM AG (equals 7,161,101 voting
rights). From these voting rights a proportion of 3.94% (equals 5,449,714
voting rights) is based on voting rights pursuant to sections 21, 22 WpHG
and a proportion of 1.24% (equals 1,711,387 voting rights) is based on
(financial / other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of
controlled undertakings: Morgan Stanley & Co International Plc; Morgan
Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services
(Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are
retransfer claims based on various contracts that can be exercised at the
lender's discretion.

3) On 11 June 2012, Morgan Stanley Group (Europe) exceeded the threshold of
5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad
Neustadt a. d. Saale, Germany. On that date, Morgan Stanley Group (Europe)
held 5.18% of the voting rights in RHÖN-KLINIKUM AG (equals 7,161,101
voting rights). From these voting rights a proportion of 3.94% (equals
5,449,714 voting rights) is based on voting rights pursuant to sections 21,
22 WpHG and a proportion of 1.24% equals 1,711,387 voting rights) is based
on (financial / other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of
controlled undertakings: Morgan Stanley UK Group; Morgan Stanley & Co
International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity
Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to
section 25 WpHG are retransfer claims based on various contracts that can
be exercised at the lender's discretion.

4) On 11 June 2012, Morgan Stanley International Limited exceeded the
threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite
1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley
International Limited held 5.18% of the voting rights in RHÖN-KLINIKUM AG
(equals 7,161,101 voting rights). From these voting rights a proportion of
3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant
to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting
rights) is based on (financial / other) instruments pursuant to section 25
WpHG. From the voting rights based on instruments pursuant to section 25
WpHG a proportion of 1.24% (equals 1,711,387 voting rights) is held
indirectly (chain of controlled undertakings: Morgan Stanley Group
(Europe); Morgan Stanley UK Group; Morgan Stanley & Co International Plc;
Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services
Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are
retransfer claims based on various contracts that can be exercised at the
lender's discretion.

5) On 11 June 2012, Morgan Stanley International Holdings Inc exceeded the
threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite
1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley
International Holdings Inc held 5.25% of the voting rights in RHÖN-KLINIKUM
AG (equals 7,260,722 voting rights). From these voting rights a proportion
of 3.94% (equals 5,449,714 voting rights) is based on voting rights
pursuant to sections 21, 22 WpHG and a proportion of 1.31% (equals
1,811,008 voting rights) is based on (financial / other) instruments
pursuant to section 25 WpHG. From the voting rights based on instruments
pursuant to section 25 WpHG a proportion of 1.31% (equals 1,811,008 voting
rights) is held indirectly (chain of controlled undertakings: MS Equity
Financing Services (Luxembourg) S.a.r.l; Morgan Stanley International
Limited; Morgan Stanley Group (Europe); Morgan Stanley UK Group; Morgan
Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan
Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments
pursuant to section 25 WpHG are retransfer claims based on various
contracts that can be exercised at the lender's discretion.

6) On 11 June 2012, Morgan Stanley exceeded the threshold of 5% of the
voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt
a. d. Saale, Germany. On that date, Morgan Stanley held 6.24% of the voting
rights in RHÖN-KLINIKUM AG (equals 8,621,399 voting rights). From these
voting rights a proportion of 4.03% (equals 5,568,769 voting rights) is
based on voting rights pursuant to sections 21, 22 WpHG and a proportion of
2.21% (equals 3,052,630 voting rights) is based on (financial / other)
instruments pursuant to section 25 WpHG. From the voting rights based on
instruments pursuant to section 25 WpHG a proportion of 2.21% (equals
3,052,630 voting rights) is held indirectly (chain of controlled
undertakings: MSDW Offshore Equity Services Inc; Fundlogic SAS; Morgan
Stanley Capital Management LLC; Morgan Stanley Domestic Holdings Inc;
Morgan Stanley & Co LLC; MS Equity Finance Services I (Cayman) Ltd; MS
Equity Financing Services (Luxembourg) S.a.r.l; Morgan Stanley
International Holdings Inc; Morgan Stanley International Limited; Morgan
Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co
International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity
Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to
section 25 WpHG are retransfer claims based on various contracts that can
be exercised at the lender's discretion.

Bad Neustadt a.d. Saale, 18 June 2012

The Board of Management
________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



18.06.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service